连全球医疗资源，享前沿医疗服务
4006 776 356
免费咨询 9:00-18:00
免费获得国外相关药品，最快 1 个工作日回馈药物信息
出境医 / 临床实验 / A Registered Cohort Study on Cerebellar Ataxia
A Registered Cohort Study on Cerebellar Ataxia
Study Description
Brief Summary:
Cerebellar ataxia is a form of ataxia originating in the cerebellum. Cerebellar ataxia can occur as a result of many diseases and may present with symptoms of an inability to coordinate balance, gait, extremity and eye movements. To understand the clinical and genetic characteristics of cerebellar ataxia, we establish a registered cohort to follow up Chinese patients with cerebellar ataxia.
| Condition or disease | Intervention/treatment |
|---|---|
| Cerebellar Ataxia | Other: No intervention |
Study Design
| Study Type : | Observational |
| Estimated Enrollment : | 1500 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | A Registered Cohort Study on Cerebellar Ataxia |
| Actual Study Start Date : | July 1, 2019 |
| Estimated Primary Completion Date : | December 2039 |
| Estimated Study Completion Date : | December 2059 |
Arms and Interventions
Outcome Measures
Primary Outcome Measures :
- The incidence of hereditary cerebellar ataxia [ Time Frame: Up to 20years ]Look for the causative gene in the patient with cerebellar ataxia
Eligibility Criteria
Contacts and Locations
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Submitted Date | July 4, 2019 | ||||||||
| First Posted Date | July 8, 2019 | ||||||||
| Last Update Posted Date | November 13, 2020 | ||||||||
| Actual Study Start Date | July 1, 2019 | ||||||||
| Estimated Primary Completion Date | December 2039 (Final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures |
The incidence of hereditary cerebellar ataxia [ Time Frame: Up to 20years ] Look for the causative gene in the patient with cerebellar ataxia
|
||||||||
| Original Primary Outcome Measures | Same as current | ||||||||
| Change History | |||||||||
| Current Secondary Outcome Measures | Not Provided | ||||||||
| Original Secondary Outcome Measures | Not Provided | ||||||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title | A Registered Cohort Study on Cerebellar Ataxia | ||||||||
| Official Title | A Registered Cohort Study on Cerebellar Ataxia | ||||||||
| Brief Summary | Cerebellar ataxia is a form of ataxia originating in the cerebellum. Cerebellar ataxia can occur as a result of many diseases and may present with symptoms of an inability to coordinate balance, gait, extremity and eye movements. To understand the clinical and genetic characteristics of cerebellar ataxia, we establish a registered cohort to follow up Chinese patients with cerebellar ataxia. | ||||||||
| Detailed Description | Not Provided | ||||||||
| Study Type | Observational | ||||||||
| Study Design | Observational Model: Cohort Time Perspective: Prospective |
||||||||
| Target Follow-Up Duration | Not Provided | ||||||||
| Biospecimen | Not Provided | ||||||||
| Sampling Method | Non-Probability Sample | ||||||||
| Study Population | Patients with cerebellar ataxia who are diagnosed in the First Affiliated Hospital of Fujian Medical University by tow neurologists. | ||||||||
| Condition | Cerebellar Ataxia | ||||||||
| Intervention | Other: No intervention
No intervention
|
||||||||
| Study Groups/Cohorts | Not Provided | ||||||||
| Publications * | Not Provided | ||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status | Recruiting | ||||||||
| Estimated Enrollment |
1500 | ||||||||
| Original Estimated Enrollment | Same as current | ||||||||
| Estimated Study Completion Date | December 2059 | ||||||||
| Estimated Primary Completion Date | December 2039 (Final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||||||
| Sex/Gender |
|
||||||||
| Ages | Child, Adult, Older Adult | ||||||||
| Accepts Healthy Volunteers | Yes | ||||||||
| Contacts |
|
||||||||
| Listed Location Countries | China | ||||||||
| Removed Location Countries | |||||||||
| Administrative Information | |||||||||
| NCT Number | NCT04010214 | ||||||||
| Other Study ID Numbers | MRCTA,ECFAH of FMU[2019]195 | ||||||||
| Has Data Monitoring Committee | Yes | ||||||||
| U.S. FDA-regulated Product |
|
||||||||
| IPD Sharing Statement | Not Provided | ||||||||
| Responsible Party | Ning Wang, MD., PhD., First Affiliated Hospital of Fujian Medical University | ||||||||
| Study Sponsor | Ning Wang, MD., PhD. | ||||||||
| Collaborators | Not Provided | ||||||||
| Investigators | Not Provided | ||||||||
| PRS Account | First Affiliated Hospital of Fujian Medical University | ||||||||
| Verification Date | November 2020 | ||||||||
